文献速递神经肌肉病

贝克肌营养不良症中肌酸激酶、肌酸/肌酐比值和肌生成抑制素作为监测生物标志物的纵向评估

Longitudinal Assessment of Creatine Kinase, Creatine/Creatinineratio, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy.
PubMed 文献 · Neurology · 2022-12-05

这项为期4年的前瞻性自然史研究纳入34例贝克肌营养不良症(BMD)患者(共106次访视),定量检测血清肌酸激酶(CK)、肌酸/肌酐比值(Cr/Crn)和肌生成抑制素,并评估功能表现。Cr/Crn和肌生成抑制素个体间高度特异(组内相关系数均为0.960),与NSAA、10米跑速度(TMRv)和6分钟步行试验(6MWT)强相关(Cr/Crn rho=-0.869至-0.801,肌生成抑制素rho=0.792至0.842,均p<0.001)。Cr/Crn、肌生成抑制素和年龄可解释NSAA、TMRv和6MWT同期功能表现高达75%的方差。

要点

  • Cr/Crn和肌生成抑制素个体间高度特异,组内相关系数均为0.960。
  • Cr/Crn与NSAA、TMRv、6MWT强负相关(rho=-0.869至-0.801,均p<0.001)。
  • 肌生成抑制素与NSAA、TMRv、6MWT强正相关(rho=0.792至0.842,均p<0.001)。

核心结论

  • Cr/Crn和肌生成抑制素可能作为BMD的监测生物标志物,较高的Cr/Crn和较低的肌生成抑制素与较低的运动表现相关,并与年龄联合时可预测同期功能表现。
  • 未来需要进一步研究以更精确地确定这些生物标志物的使用背景。

研究设计与样本

  • 为期4年的前瞻性自然史研究,纳入34例BMD患者,共106次访视。
  • 基线时8例患者不能行走。
  • 采用国际临床化学联合会参考方法定量检测血清CK,液相色谱-串联质谱法检测Cr/Crn,ELISA检测肌生成抑制素。
  • 功能评估包括北极星步行评估(NSAA)、10米跑速度(TMRv)、6分钟步行试验(6MWT)和用力肺活量。
  • 采用毛细管Western免疫分析法定量检测胫骨前肌中的抗肌萎缩蛋白水平。

主要发现

  • Cr/Crn和肌生成抑制素个体间高度特异,组内相关系数均为0.960。
  • Cr/Crn与NSAA、TMRv和6MWT强负相关(rho=-0.869至-0.801,均p<0.001);肌生成抑制素与NSAA、TMRv和6MWT强正相关(rho=0.792至0.842,均p<0.001)。
  • CK与年龄呈负相关(p=0.0002),但与患者功能表现无关。
  • Cr/Crn和肌生成抑制素与6MWT年均变化量中等相关(rho=-0.532和0.555,p=0.02)。
  • 抗肌萎缩蛋白水平与所选生物标志物及功能表现均不相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来需要进一步研究以更精确地确定这些生物标志物的使用背景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The slow and variable disease progression of Becker muscular dystrophy (BMD) urges the development of biomarkers to facilitate clinical trials. We explored changes in 3 muscle-enriched biomarkers in serum of patients with BMD over 4-year time and studied associations with disease severity, disease progression, and dystrophin levels in BMD. METHODS: We quantitatively measured creatine kinase (CK) using the International Federation of Clinical Chemistry reference method, creatine/creatinineratio (Cr/Crn) using liquid chromatography-tandem mass spectrometry, and myostatin with ELISA in serum and assessed functional performance using the North Star Ambulatory Assessment (NSAA), 10-meter run velocity (TMRv), 6-Minute Walking Test (6MWT), and forced vital capacity in a 4-year prospective natural history study. Dystrophin levels were quantified in the tibialis anterior muscle using capillary Western immunoassay. The correlation between biomarkers, age, functional performance, mean annual change, and prediction of concurrent functional performance was analyzed using linear mixed models. RESULTS: Thirty-four patients with 106 visits were included. Eight patients were nonambulant at baseline. Cr/Crn and myostatin were highly patient specific (intraclass correlation coefficient for both = 0.960). Cr/Crn was strongly negatively correlated, whereas myostatin was strongly positively correlated with the NSAA, TMRv, and 6MWT (Cr/Crn rho = -0.869 to -0.801 and myostatin rho = 0.792 to 0.842, all p < 0.001). CK showed a negative association with age (p = 0.0002) but was not associated with patients' performance. Cr/Crn and myostatin correlated moderately with the average annual change of the 6MWT (rho = -0.532 and 0.555, p = 0.02). Dystrophin levels did not correlate with the selected biomarkers nor with performance. Cr/Crn, myostatin, and age could explain up to 75% of the variance of concurrent functional performance of the NSAA, TMRv, and 6MWT. DISCUSSION: Both Cr/Crn and myostatin could potentially serve as monitoring biomarkers in BMD, as higher Cr/Crn and lower myostatin were associated with lower motor performance and predictive of concurrent functional performance when combined with age. Future studies are needed to more precisely determine the context of use of these biomarkers.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. van de Velde NM, Koeks Z, Signorelli M, et al. Longitudinal Assessment of Creatine Kinase, Creatine/Creatinineratio, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy. Neurology. 2022. PMID: 36849458. doi:10.1212/WNL.0000000000201609

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。